AKT1 and medulloblastoma: For example, Rapamycin inhibitors of PI3K/AKT/mTOR signaling pathway and SMO inhibitors of hedgehog signaling pathway significantly delayed the development of drug resistance in Medulloblastoma (Krishnamurthy and kurzrock, 2018; Buonamici et al., 2010).